Compound: O-1602
SMILES: Oc1c(c(cc(c1)O)C)[C@@H]2C=C(CC[C@H]2C(=C)C)C
InChIKey: KDZOUSULXZNDJH-LSDHHAIUSA-N
Synonyms: O-1602, 317321-41-8, 5-METHYL-4-[(1R,6R)-3-METHYL-6-(1-METHYLETHENYL)-2-CYCLOHEXEN-1-YL]-1,3-BENZENEDIOL, 59F4R2N5N5, DTXSID001018640, 5-methyl-4-[(1R,6R)-3-methyl-6-prop-1-en-2-ylcyclohex-2-en-1-yl]benzene-1,3-diol, 5-Methyl-4-((1R,6R)-3-methyl-6-(1-methylethenyl)-2-cyclohexen-1-yl)-1,3-benzenediol, 5-methyl-4-((1R,6R)-3-methyl-6-prop-1-en-2-ylcyclohex-2-en-1-yl)benzene-1,3-diol, RefChem:167116, DTXCID901476712, O 1602, CHEMBL3402654, O1602, (1'R,2'R)-5',6-dimethyl-2'-(prop-1-en-2-yl)-1',2',3',4'-tetrahydro[1,1'-biphenyl]-2,4-diol, O-1602 compound, O-1602 (Standard), BXF9RU99NM, UNII-59F4R2N5N5, GTPL5525, orb1704273, SCHEMBL3763279, SCHEMBL30259706, GLXC-01504, HMS3649P12, BDBM50552131, MFCD08062192, AKOS024457297, AT28248, HY-107541R, 5-methyl-4-[(1R,6R)-3-methyl-6-(prop-1-en-2-yl)cyclohex-2-en-1-yl]benzene-1,3-diol, MS-33335, DB-306747, HY-107541, CS-0028845, SR-01000946749, SR-01000946749-1, Q15409358, 1,3-Benzenediol, 5-methyl-4-[(1R,6R)-3-methyl-6-(1-methylethenyl)-2-cyclohexen-1-yl]-, 4-[(1R,6R)-6-isopropenyl-3-methyl-cyclohex-2-en-1-yl]-5-methyl-benzene-1,3-diol, 5-Methyl -4-[(1r,6r)-3-methyl -6-(1-methylethenyl )-2-cyclohexen-1-yl ]-1,3-benzenediol, 5-methyl-4-[(1R, 6R)-3-methyl-6-(1-methylethenyl)-2-cyclohexen-1-yl]-1,3-benzenediol, rel-5-Methyl-4-[(1R,6R)-3-methyl-6-(1-methylethenyl)-2-cyclohexen-1-yl]-1,3-benzenediol, 1,3-Benzenediol, 5-methyl-4-[(1R,6R)-3-methyl-6-(1-methylethenyl)-2-cyclohexen-1-yl]-, rel-, 1884645-10-6, 5-?Methyl-?4-?[(1R,?6R)-?3-?methyl-?6-?(1-?methylethenyl)-?2-?cyclohexen-?1-?yl]-?1,?3-?benzenediol, 5-Methyl-4-[(1R,6R)-3-methyl-6-(1-methylethenyl)-2-cyclohexen-1-yl]-1,3-benzenediol, rel-, HVJ
Theoretical properties:
molecular_formula: C17H22O2
molecular_weight: 258.35 g/mol
exact_mass: 258.161979940 g/mol
formal_charge: 0
hydrogen_bond_donor_count: 2
hydrogen_bond_acceptor_count: 2
rotatable_bond_count: 2
heavy_atom_count: 19
topological_polar_surface_area: 40.5 Å²
isotope_atom_count: 0
covalently_bonded_unit_count: 1
Physical properties:
Descriptions:
chembl: Unnamed Compound is a small molecule listed in the ChEMBL database but has not progressed to an approved clinical phase.
wikipedia: O-1602 is a synthetic compound most closely related to abnormal cannabidiol, and more distantly related in structure to cannabinoid drugs such as THC. O-1602 does not bind to the classical cannabinoid receptors CB1 or CB2 with any significant affinity, but instead is an agonist at several other receptors which appear to be related to the cannabinoid receptors, particularly GPR18 and GPR55. These previously orphan receptors have been found to be targets for a number of endogenous and synthetic cannabinoid compounds, and are thought to be responsible for most of the non-CB1, non-CB2 mediated effects that have become evident in the course of cannabinoid research. O-1602 produces some effects shared with classical cannabinoid compounds such as analgesic and antiinflammatory effects and appetite stimulation, but it does not produce sedation or psychoactive effects, and has several actions in the gut and brain that are not shared with typical cannabinoid agonists.